Search

Integra LifeSciences Holdings Corp

Затворен

СекторЗдравеопазване

17.14 -1.83

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

17.09

Максимум

18.23

Ключови измерители

By Trading Economics

Приходи

9.2M

4.6M

Продажби

27M

419M

EPS

0.56

Марж на печалбата

1.103

Служители

4,427

EBITDA

3M

66M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+9.91% upside

Дивиденти

By Acuity

Следващи печалби

29.10.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-146M

1.4B

Предишно отваряне

18.97

Предишно затваряне

17.14

Настроения в новините

By Acuity

25%

75%

81 / 340 Класиране в Healthcare

Integra LifeSciences Holdings Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

18.08.2026 г., 21:01 ч. UTC

Integra Lifesciences Holdings Corp shares are trading lower in after-market hours, influenced by broader market caution amid rising bond yields and inflation concerns.

17.08.2026 г., 21:01 ч. UTC

Integra Lifesciences shares are lower in after-market hours, reflecting broader market pressures from rising crude oil prices and increasing long-term Treasury yields.

14.08.2026 г., 20:06 ч. UTC

Integra Lifesciences Holdings Corp is trading higher today, recovering from an initial dip and remaining above its 20-day moving average. No specific news was identified.

13.08.2026 г., 20:06 ч. UTC

Integra Lifesciences Holdings Corp shares are higher, reflecting broader market trends amid rising initial jobless claims. No specific company news was identified.

12.08.2026 г., 23:31 ч. UTC

Integra Lifesciences Holdings Corp shares are higher in after-market trading, buoyed by easing inflation concerns and broader market trends. No specific news was identified.

10.08.2026 г., 20:06 ч. UTC

Integra Lifesciences Holdings Corp shares are lower today, following a volatile session that included an initial gain before declining to a session low.

7.08.2026 г., 19:16 ч. UTC

News

Integra Lifesciences reported flat revenue of $418.8 million and adjusted EPS of $0.56, exceeding expectations. Shares are advancing in response to the earnings results.

6.08.2026 г., 19:36 ч. UTC

Integra Lifesciences Holdings Corp shares are lower today, continuing a decline since Wednesday's close. The stock remains below its 20-day moving average.

5.08.2026 г., 19:36 ч. UTC

Integra Lifesciences Holdings Corp shares are lower today, continuing a decline since Tuesday's close. The stock remains significantly below its 20-day moving average.

4.08.2026 г., 19:46 ч. UTC

Integra Lifesciences Holdings Corp shares are lower during Tuesday's session, approximately 3.60% below the 20-day moving average, with no specific news identified.

3.08.2026 г., 20:51 ч. UTC

Integra Lifesciences Holdings Corp gains in after-market hours, reflecting broader market optimism despite no specific company news. Major indices also show significant increases.

31.07.2026 г., 19:46 ч. UTC

Integra Lifesciences Holdings Corp shares are lower during Friday's session, trading near the lower end of their one-month range with no specific news identified.

30.07.2026 г., 17:41 ч. UTC

Integra Lifesciences Holdings Corp shares are higher today, despite earlier session pullbacks. No specific news was identified to explain the movement.

29.07.2026 г., 21:01 ч. UTC

Integra Lifesciences shares are lower in after-market hours, reflecting a broader decline in U.S. equities amid rising oil prices and geopolitical tensions.

28.07.2026 г., 20:03 ч. UTC

News

Shares of Integra Lifesciences Holdings are higher, supported by UBS's Neutral rating and price target of $19 amid broader Health Care Equipment gains.

27.07.2026 г., 19:51 ч. UTC

Integra Lifesciences Holdings Corp shares are lower today amid notable volatility, despite remaining near the upper end of their one-month trading range.

24.07.2026 г., 19:02 ч. UTC

News

Integra Lifesciences shares are higher today, following a downgrade from Wall Street Zen and a price target increase from Truist Financial to $19.00.

21.07.2026 г., 18:46 ч. UTC

Integra Lifesciences Holdings shares are higher amid broader market recovery, despite a slight pullback from earlier gains. The stock remains above its 20-day moving average.

20.07.2026 г., 19:26 ч. UTC

News

Integra Lifesciences Holdings is lower amid broader market pressure from rising Treasury yields. Investors await upcoming quarterly results after exceeding earnings expectations.

Сравнение с други в отрасъла

Ценова промяна

Integra LifeSciences Holdings Corp Прогноза

Ценова цел

By TipRanks

9.91% нагоре

12-месечна прогноза

Среден 19.29 USD  9.91%

Висок 25 USD

Нисък 17 USD

Според 8 анализатори от Wall Street, предложили 12-месечна ценова цел за Integra LifeSciences Holdings Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

8 ratings

1

Купи

6

Задържане

1

Продай

Настроение

By Acuity

81 / 340 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat